TRCPX | VIVIX | TRCPX / VIVIX | |
Total Expense Ratio | 0.56 | 0.04 | 1,400% |
Annual Report Gross Expense Ratio | 0.56 | 0.04 | 1,400% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 10.930 | 8.260 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.38B | 196B | 3% |
Annual Yield % from dividends | 1.18 | 2.11 | 56% |
Returns for 1 year | 7.67 | 7.13 | 108% |
Returns for 3 years | 30.19 | 35.07 | 86% |
Returns for 5 years | 54.32 | 69.21 | 78% |
Returns for 10 years | 60.51 | 138.81 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EQIDX | 13.54 | -0.01 | -0.07% |
Allspring Emerging Markets Eq Advtg Adm | |||
ICMBX | 13.58 | -0.02 | -0.15% |
Intrepid Capital Investor | |||
GCMAX | 38.34 | -0.09 | -0.23% |
Goldman Sachs Mid Cap Value A | |||
VPMCX | 179.41 | -0.71 | -0.39% |
Vanguard PRIMECAP Inv | |||
GVIRX | 18.20 | -0.08 | -0.44% |
Goldman Sachs US Eq Div and Premium Inv |